HCAT icon

Health Catalyst

6.89 USD
+0.00
0.00%
At close Jan 10, 4:00 PM EST
After hours
6.81
-0.08
1.16%
1 day
0.00%
5 days
-6.89%
1 month
-17.68%
3 months
-12.23%
6 months
17.58%
Year to date
-6.13%
1 year
-37.36%
5 years
-81.28%
10 years
-82.41%
 

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,300

0
Funds holding %
of 6,810 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

4,933% more call options, than puts

Call options by funds: $23.3M | Put options by funds: $463K

29% more capital invested

Capital invested by funds: $336M [Q2] → $433M (+$97.5M) [Q3]

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

2% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 50

0% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]

1% less funds holding

Funds holding: 160 [Q2] → 159 (-1) [Q3]

0.9% less ownership

Funds ownership: 89.1% [Q2] → 88.2% (-0.9%) [Q3]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$9
31%
upside
Avg. target
$9.80
42%
upside
High target
$12
74%
upside

5 analyst ratings

positive
60%
neutral
40%
negative
0%
Citigroup
Daniel Grosslight
43% 1-year accuracy
10 / 23 met price target
45%upside
$10
Buy
Maintained
10 Jan 2025
Keybanc
Scott Schoenhaus
36% 1-year accuracy
13 / 36 met price target
31%upside
$9
Overweight
Upgraded
8 Jan 2025
Piper Sandler
Jessica Tassan
29% 1-year accuracy
6 / 21 met price target
74%upside
$12
Overweight
Reiterated
26 Nov 2024
Stephens & Co.
Jeff Garro
50% 1-year accuracy
3 / 6 met price target
31%upside
$9
Equal-Weight
Maintained
14 Nov 2024
RBC Capital
Sean Dodge
53% 1-year accuracy
23 / 43 met price target
31%upside
$9
Sector Perform
Maintained
7 Nov 2024

Financial journalist opinion

Neutral
Seeking Alpha
3 weeks ago
Health Catalyst: Improved Demand Environment Reinforces My Buy Rating
Despite positive demand and fundamentals, I believe the market undervalues HCAT's growth potential. Gross margin contraction is due to temporary headwinds, which should ease, leading to strong margin expansion. Risks include potential delays in growth acceleration and macroeconomic uncertainties.
Health Catalyst: Improved Demand Environment Reinforces My Buy Rating
Neutral
GlobeNewsWire
1 month ago
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation on Wednesday, January 15, 2025, at 10:30 am PT. The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com.
Health Catalyst to Participate in Upcoming Investor Conference
Neutral
PRNewsWire
1 month ago
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
SALT LAKE CITY , Nov. 20, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of an AI-powered version of BluePrint Protect™ from Intraprise Health, LLC ("Intraprise Health"), a platform that empowers healthcare organizations to screen and identify risks related to cybersecurity threats through third parties. On Nov. 6, Health Catalyst announced it signed a definitive agreement to acquire Intraprise Health, a tech-enabled cybersecurity provider offering an end-to-end cybersecurity risk management platform and services to protect healthcare clients from cyberattacks and manage follow-on liability in the event of an incident.
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
Neutral
GlobeNewsWire
1 month ago
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Stephens Annual Investment Conference, being held in Nashville, including a fireside chat on Wednesday, November 20, 2024, at 1:00 pm CT.
Health Catalyst to Participate in Upcoming Investor Conference
Neutral
Seeking Alpha
2 months ago
Health Catalyst, Inc. (HCAT) Q3 2024 Earnings Call Transcript
Health Catalyst, Inc. (NASDAQ:HCAT ) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO Dan LeSueur - COO Jason Alger - CFO Conference Call Participants Jared Haase - William Blair Jessica Tassan - Piper Sandler Anna Kruszenski - Barclays Bank John Pinney - Canaccord Genuity Thomas Kelliher - RBC Capital Markets David Larsen - BTIG John Ransom - Raymond James Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Operator Welcome to the Health Catalyst Third Quarter 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.
Health Catalyst, Inc. (HCAT) Q3 2024 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings
While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings
Neutral
Zacks Investment Research
2 months ago
Health Catalyst (HCAT) Q3 Earnings Miss Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.03 per share a year ago.
Health Catalyst (HCAT) Q3 Earnings Miss Estimates
Neutral
PRNewsWire
2 months ago
Nationally Recognized Healthcare Executive Dr. Jill Hoggard Green Joins Health Catalyst Board of Directors
SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jill Hoggard Green, RN, BSN, MS, PhD, FAAN, former Chief Executive Officer of The Queen's Health Systems, has been appointed to serve as a member of Health Catalyst's board of directors ("Board") and a member of its Compensation Committee, effective December 1, 2024. "Jill has been an extraordinary leader throughout her career.
Nationally Recognized Healthcare Executive Dr. Jill Hoggard Green Joins Health Catalyst Board of Directors
Neutral
PRNewsWire
2 months ago
CyncHealth Selects Health Catalyst to Elevate Health Data Management
SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a new partnership with CyncHealth, the designated statewide health information exchange (HIE) for Iowa. This partnership will enhance CyncHealth's ability to provide comprehensive and timely patient health information to healthcare providers.
CyncHealth Selects Health Catalyst to Elevate Health Data Management
Neutral
PRNewsWire
2 months ago
Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health
SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Intraprise Health, LLC ("Intraprise"), a tech-enabled cybersecurity provider offering an end-to-end cybersecurity risk management platform and services to protect its clients from cyberattacks and manage follow-on liability in the event of an incident. Health Catalyst anticipates the acquisition will close in the fourth quarter of 2024.
Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health
Charts implemented using Lightweight Charts™